FDA Approves First Biosimilar to Treat Multiple Sclerosis Tyruko (natalizumab-sztn)

https://www.fda.gov/news-events/press-announcements/fda-approves-first-biosimilar-treat-multiple-sclerosis?utm_medium=email&utm_source=govdelivery